HK1253006A1 - 製備截短側耳素的工藝 - Google Patents

製備截短側耳素的工藝

Info

Publication number
HK1253006A1
HK1253006A1 HK18112372.3A HK18112372A HK1253006A1 HK 1253006 A1 HK1253006 A1 HK 1253006A1 HK 18112372 A HK18112372 A HK 18112372A HK 1253006 A1 HK1253006 A1 HK 1253006A1
Authority
HK
Hong Kong
Prior art keywords
pleuromutilins
preparation
Prior art date
Application number
HK18112372.3A
Other languages
English (en)
Inventor
Rosemarie Riedl
Werner Heilmayer
Lee Spence
Original Assignee
Nabriva Therapeutics GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nabriva Therapeutics GmbH filed Critical Nabriva Therapeutics GmbH
Publication of HK1253006A1 publication Critical patent/HK1253006A1/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C319/00Preparation of thiols, sulfides, hydropolysulfides or polysulfides
    • C07C319/14Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides
    • C07C319/20Preparation of thiols, sulfides, hydropolysulfides or polysulfides of sulfides by reactions not involving the formation of sulfide groups
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/40Y being a hydrogen or a carbon atom
    • C07C323/41Y being a hydrogen or an acyclic carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/23Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
    • C07C323/39Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton at least one of the nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom
    • C07C323/43Y being a hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/52Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C53/00Saturated compounds having only one carboxyl group bound to an acyclic carbon atom or hydrogen
    • C07C53/08Acetic acid
    • C07C53/10Salts thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13Dicarboxylic acids
    • C07C57/145Maleic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/01Saturated compounds having only one carboxyl group and containing hydroxy or O-metal groups
    • C07C59/08Lactic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14The ring being saturated
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/76Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members
    • C07C2603/80Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings
    • C07C2603/82Ring systems containing bridged rings containing three rings containing at least one ring with more than six ring members containing eight-membered rings having three condensed rings with in total fourteen carbon atoms and having a having a [5.4.3.0(1,8)] ring structure, e.g. pleuromutiline
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK18112372.3A 2010-05-26 2018-09-27 製備截短側耳素的工藝 HK1253006A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20100450092 EP2399904A1 (en) 2010-05-26 2010-05-26 Process for the preparation of pleuromutilins

Publications (1)

Publication Number Publication Date
HK1253006A1 true HK1253006A1 (zh) 2019-06-06

Family

ID=42937801

Family Applications (1)

Application Number Title Priority Date Filing Date
HK18112372.3A HK1253006A1 (zh) 2010-05-26 2018-09-27 製備截短側耳素的工藝

Country Status (29)

Country Link
US (1) US9120727B2 (zh)
EP (3) EP2399904A1 (zh)
JP (2) JP6038021B2 (zh)
KR (1) KR101935333B1 (zh)
CN (2) CN103080083B (zh)
AU (1) AU2011257938B2 (zh)
BR (1) BR112012029982A2 (zh)
CA (1) CA2799029C (zh)
DK (2) DK3299356T3 (zh)
EA (1) EA023273B1 (zh)
ES (2) ES2659729T3 (zh)
HK (1) HK1253006A1 (zh)
HR (1) HRP20220201T1 (zh)
HU (2) HUE057587T2 (zh)
IL (1) IL222999A (zh)
MA (1) MA34332B1 (zh)
MX (1) MX347176B (zh)
MY (1) MY164666A (zh)
NZ (1) NZ603804A (zh)
PL (2) PL3299356T3 (zh)
PT (2) PT2576505T (zh)
SG (1) SG185104A1 (zh)
SI (1) SI3299356T1 (zh)
TN (1) TN2012000506A1 (zh)
TR (1) TR201802636T4 (zh)
TW (1) TWI585073B (zh)
UA (1) UA108378C2 (zh)
WO (1) WO2011146954A1 (zh)
ZA (1) ZA201208056B (zh)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104447294A (zh) * 2014-11-24 2015-03-25 苏州乔纳森新材料科技有限公司 一种3-环己烯-1-甲酸的手性拆分方法
EP3310331B1 (en) * 2015-06-17 2020-10-14 Nabriva Therapeutics GMBH Injectable pharmaceutical formulations of lefamulin
KR102664563B1 (ko) 2015-06-18 2024-05-09 에스테트라, 소시에떼 아 레스폰서빌리떼 리미떼 에스테트롤 성분을 함유하는 구강분해성 투여 단위
SI3310333T1 (sl) 2015-06-18 2020-08-31 Estetra Sprl Orodisperzibilna enota odmerka, ki vsebuje komponento estetrola
TWI762573B (zh) * 2017-02-10 2022-05-01 奧地利商納畢瓦治療有限責任公司 截短側耳素之純化
CN107417586A (zh) * 2017-06-21 2017-12-01 华南农业大学 一种截短侧耳素类抗生素及其制备方法和应用
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
TWI755055B (zh) * 2019-09-18 2022-02-11 台灣神隆股份有限公司 用於製備惡拉戈利鈉及其中間體的方法
CN111170893B (zh) * 2020-01-19 2022-04-26 郑州依米花手性药物研究有限公司 Lefamulin的中间体化合物及其在Lefamulin制备中的应用
WO2021209173A1 (en) 2020-04-17 2021-10-21 Nabriva Therapeutics GmbH Novel therapeutic use of pleuromutilins
CN115443131A (zh) * 2020-04-17 2022-12-06 纳布里瓦治疗有限责任公司 截短侧耳素类化合物的治疗用途
WO2023152115A1 (en) 2022-02-09 2023-08-17 Nabriva Therapeutics GmbH Lefamulin and its derivatives for use in the treatment of a spiral shaped bacteria
EP4338732A1 (en) 2022-09-16 2024-03-20 Nabriva Therapeutics GMBH Lefamulin and its derivatives for use in the treatment of tularemia

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61207370A (ja) * 1985-03-11 1986-09-13 Seitetsu Kagaku Co Ltd 4−(メタンスルホニルオキシ)チオフエノ−ルの製法
GB0017031D0 (en) * 2000-07-11 2000-08-30 Biochemie Gmbh Antimicrobials
SI1534678T1 (sl) * 2002-07-24 2008-06-30 Nabriva Therapeutics Ag Plevromutilinski derivati kot antimikrobna sredstva
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
ATE386014T1 (de) * 2003-08-04 2008-03-15 Grindeks Jsc Meldoniumsalze, verfahren zu deren herstellung und auf ihnen basierende pharmazeutische zusammensetzung
US7772240B2 (en) * 2003-08-18 2010-08-10 H. Lundbeck A/S Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
US7875630B2 (en) * 2003-09-03 2011-01-25 Glaxo Group Limited Process salts compositions and use
WO2008011089A2 (en) 2006-07-20 2008-01-24 Wms Gaming Inc. Wagering game with special-event eligibility feature based on passive game play
EP1908750A1 (en) * 2006-10-05 2008-04-09 Nabriva Therapeutics Forschungs GmbH Process for the preparation of pleuromutilins
SI1961735T1 (sl) * 2007-02-22 2010-01-29 Indena Spa Postopek za pripravo acetatne soli (2r,3s)-3-fenilizoserin-metilestra
EP1972618A1 (en) 2007-03-20 2008-09-24 Nabriva Therapeutics AG Pleuromutilin derivatives for the treatment of diseases mediated by microbes
EP2014645A1 (en) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives and their use as antimicrobials
EP2159220A1 (en) * 2008-09-02 2010-03-03 Nabriva Therapeutics AG Organic compounds

Also Published As

Publication number Publication date
ES2659729T3 (es) 2018-03-19
TN2012000506A1 (en) 2014-04-01
PT3299356T (pt) 2022-02-21
CN105111117A (zh) 2015-12-02
US9120727B2 (en) 2015-09-01
TW201209026A (en) 2012-03-01
DK3299356T3 (da) 2022-01-31
EP2399904A1 (en) 2011-12-28
KR20130079406A (ko) 2013-07-10
EP3299356B1 (en) 2021-11-24
ZA201208056B (en) 2014-01-29
TWI585073B (zh) 2017-06-01
MX347176B (es) 2017-04-17
US20130079400A1 (en) 2013-03-28
TR201802636T4 (tr) 2018-03-21
HUE035861T2 (hu) 2018-06-28
JP6038021B2 (ja) 2016-12-07
EP3299356A1 (en) 2018-03-28
EP2576505B1 (en) 2017-11-29
DK2576505T3 (en) 2018-03-05
MA34332B1 (fr) 2013-06-01
EP2576505A1 (en) 2013-04-10
BR112012029982A2 (pt) 2020-09-01
JP2013528162A (ja) 2013-07-08
HRP20220201T1 (hr) 2022-04-29
PT2576505T (pt) 2018-03-05
EA023273B1 (ru) 2016-05-31
JP6501742B2 (ja) 2019-04-17
EA201291370A1 (ru) 2013-09-30
IL222999A (en) 2016-02-29
ES2909198T3 (es) 2022-05-05
SI3299356T1 (sl) 2022-05-31
CA2799029A1 (en) 2011-12-01
WO2011146954A1 (en) 2011-12-01
KR101935333B1 (ko) 2019-01-04
CN103080083B (zh) 2016-03-02
AU2011257938B2 (en) 2016-06-23
SG185104A1 (en) 2012-12-28
PL2576505T3 (pl) 2018-05-30
JP2016210804A (ja) 2016-12-15
NZ603804A (en) 2014-03-28
MX2012013645A (es) 2013-05-01
HUE057587T2 (hu) 2022-05-28
UA108378C2 (uk) 2015-04-27
MY164666A (en) 2018-01-30
IL222999A0 (en) 2013-02-03
PL3299356T3 (pl) 2022-04-04
CA2799029C (en) 2019-01-29
CN103080083A (zh) 2013-05-01

Similar Documents

Publication Publication Date Title
HK1253006A1 (zh) 製備截短側耳素的工藝
EP2552874A4 (en) PROCESS FOR PREPARING HEXAFLUOR-2 BUTENE
ZA201103820B (en) Process for the preparation of tenofovir
ZA201202504B (en) Process for the preparation of calcobutrol
EP2558432A4 (en) METHOD FOR THE PRODUCTION OF TETRAFLUOROLEFINES
PL2632889T3 (pl) Związki pośrednie i sposób wytwarzania fingolimodu
PL390042A1 (pl) Sposób wytwarzania kwasu chlebowego
SG11201400939YA (en) Process for the preparation of methoxymelonal
PL388931A1 (pl) Sposób otrzymywania fluorokarbofunkcyjnych silseskwioksanów
HUE044066T2 (hu) Eljárás metilén-difenil-diizocianát elõállítására
EP2596007A4 (en) PROCESS FOR THE PREPARATION OF 17-DEOXY-CORTICOSTEROIDS
ZA201300546B (en) Process for the preparation of 3-haloalkylpyrazoles
PT2593423E (pt) Processo para a preparação de agentes de contraste
PT2603319E (pt) Processo para a preparação de uretanos
PT2390246T (pt) Processo para a preparação de aminaftona
PL2702045T3 (pl) Nowy sposób sporządzania Etrawiryny
HUP1000018A2 (en) Process for the preparation of distrontium ranelate
PT2598504E (pt) Novo processo de fabrico de dimiracetam
IL224304A (en) A process for making dichlorobulben
PL391539A1 (pl) Sposób wytwarzania tworzyw akrylowo-formaldehydowo-mocznikowych
PL394420A1 (pl) Sposób wytwarzania dilauroilofluoresceiny
PL394378A1 (pl) Sposób otrzymywania E-2-amino-4-nitrostilbenów
PL390811A1 (pl) Sposób otrzymywania glicydolu
PL390812A1 (pl) Sposób otrzymywania glicydolu
PL391571A1 (pl) Sposób otrzymywania katalizatorów oksyalkilenowania